Homealkahest

  • Parkinson’s drug ALK4290 by Alkahest receives Grant for Preclinical Evaluation

    • May 31, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Phase 2 Clinical Trial of GRF6019 in Alzheimer’s Disease initiated by Alkahest

    • April 26, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more